A Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Study of ACE-031 (ActRIIB-IgG1)in Healthy Postmenopausal Volunteers

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2008
Single center, randomized, single dose study to evaluate the safety, tolerability, pharmacokinetic and pharmacodynamic effects of ACE-031 in healthy postmenopausal volunteers
Epistemonikos ID: 7b3defb03fafb679916f29b021ee223fe677b25c
First added on: May 05, 2024